Full text
42,938 characters
· extracted from
preprint-html
· click to expand
Features of mobile apps for diabetic kidney disease self-management: a scoping review | medRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-P4HH5NV'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search Features of mobile apps for diabetic kidney disease self-management: a scoping review View ORCID Profile Hasmawati Yahya , View ORCID Profile Nani Draman , Azidah Abdul Kadir , Najib Majdi Yaacob doi: https://doi.org/10.1101/2025.08.20.25334066 Hasmawati Yahya 1 School of Medical Science, Health Campus, Universiti Sains Malaysia 16150 Kubang Kerian, Kelantan, Malaysia Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Hasmawati Yahya Nani Draman 2 Department of Family Medicine, School of Medical Science, Health Campus, Universiti Sains Malaysia 16150 Kubang Kerian, Kelantan, Malaysia Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Nani Draman For correspondence: drnani{at}usm.my Azidah Abdul Kadir 2 Department of Family Medicine, School of Medical Science, Health Campus, Universiti Sains Malaysia 16150 Kubang Kerian, Kelantan, Malaysia Find this author on Google Scholar Find this author on PubMed Search for this author on this site Najib Majdi Yaacob 3 Department of Biostatistics and Research Methodology, Health Campus, Universiti Sains Malaysia , 16150 Kubang Kerian, Kelantan, Malaysia Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Full Text Info/History Metrics Data/Code Preview PDF Abstract Background Diabetic kidney disease (DKD) is a chronic complication of diabetes mellitus (DM). DKD and chronic kidney disease (CKD) are both long-term conditions requiring ongoing patient care. Individuals living with DKD or CKD can benefit from mobile apps that support effective self-management. However, limited evidence is available about what mobile apps features are commonly included for DKD. Objective This scoping review aimed to identify the features of mobile applications on self-management for individuals with DKD, DM or CKD. Methods The review followed the Joanna Briggs Institute (JBI) methodology for scoping reviews and adhered to PRISMA-ScR reporting guidelines. Five databases (PubMed, Scopus, SAGE Journals, ScienceDirect, and Web of Science) were searched from inception to February 26, 2025. Studies were included if they reported on mobile apps supporting self-management in adults with DKD, DM or CKD. DM and CKD apps were included due to similar self-management needs such as blood sugar or blood pressure tracking that are also relevant to people with DKD. Data were extracted on study characteristics, app features, use of technology, integration with care teams, and reported outcomes. Results Out of 3521 records identified, eleven studies met the inclusion criteria. Five studies focused on CKD, two on DKD, and four on diabetes. Across the eleven mobile apps reviewed, four core domains of self-management were identified: self-care monitoring (91%), educational components (64%), patient support and motivation (100%), and performance incentives (18%). Four apps employed wearable devices and incorporated supportive devices such as Bluetooth glucometers. However, only two apps included real-time communication features with providers integration with healthcare teams and gamification strategies. Conclusions Mobile apps targeting DKD frequently incorporate monitoring, education, and motivational features. However, consistent integration with healthcare providers and incentive-based engagement strategies remains limited. Future app development should emphasise personalised feedback, clinical integration, and sustained engagement mechanisms to enhance usability and impact. Introduction Diabetes and chronic kidney disease (CKD) are two significant global health challenges that often coexist and interact. Diabetic kidney disease (DKD), a condition that emerges when diabetes leads to progressive kidney damage, is one of the most serious long-term complications of diabetes. It significantly increases the risk of kidney failure, cardiovascular disease, and premature death. Managing these conditions requires patients to take on various daily tasks, such as monitoring blood glucose or blood pressure, adhering to medications, making dietary changes, and engaging in healthy lifestyle behaviours. These self-management responsibilities can be overwhelming for many individuals, especially without structured support [ 1 , 2 ]. In recent years, mobile applications (apps) have gained attention as practical and scalable tools for self-management of chronic diseases like diabetes and CKD. These apps offer a variety of features that can help patients better understand their condition, track health metrics, receive medication or appointment reminders, and access educational content on diet, exercise, and symptoms. Because mobile phones are widely accessible and integrated into many people’s daily lives, mobile apps have become a convenient and potentially impactful way to enhance disease self-care [ 3 ]. Self-management refers to an individual’s ability to manage the symptoms, treatment, lifestyle changes, and psychosocial consequences of living with a chronic condition. It emphasizes active participation in care, including making informed decisions, adhering to treatment plans, and engaging in behaviors that promote health and well-being [ 4 , 5 ].In the context of diabetic kidney disease and chronic kidney disease effective self-management is linked to improved clinical outcomes, greater self-efficacy, and reduced healthcare utilization [ 6 , 7 ]. Despite the growing number of mobile apps developed for diabetes or CKD individually, relatively few are designed specifically for people with DKD. However, because DKD is closely linked to both diabetes and CKD, mobile apps built for either condition often include overlapping features such as blood glucose and blood pressure monitoring, medication reminders, educational content, and provider communication tools that are also relevant for DKD management [ 3 , 8 ]. Including mobile apps targeting diabetes, CKD, and DKD in this review enables a more comprehensive assessment of how digital health tools support self-management across these interrelated conditions [ 11 – 21 ]. Therefore, this scoping review aims to explore and map the key features of mobile applications developed to support self-management for people living with diabetes, CKD, or DKD. Looking across all three conditions helps provide a complete picture of how mobile technology supports important health behaviours like monitoring, education, motivation, and treatment adherence. By understanding what’s already available and how these features are used, this review hopes to highlight areas where mobile app development is doing well and where more tailored, patient-centred solutions may still be needed [ 2 , 3 ]. Material and methods This scoping review was conducted in accordance with the Joanna Briggs Institute (JBI) methodology for scoping reviews and reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist. The research questions in this scoping review were developed using the Joanna Briggs Institute’s Population–Concept–Context (PCC) framework to ensure alignment with scoping review methodology [ S1 Table ]. The population of interest includes individuals diagnosed with both diabetes and chronic kidney disease (CKD) or diabetic kidney disease (DKD). The concept explored is self-management, which refers to patients’ active participation in managing their health conditions. The context focuses on the use of mobile applications that support these self-management activities. The PCC elements guiding this review are summarized in Table 1 . View this table: View inline View popup Download powerpoint Table 1. PCC Framework for the scoping review research questions Protocol and registration No protocol was registered for this scoping review. However, the methodology followed the Joanna Briggs Institute (JBI) guidelines for conducting scoping reviews and adhered to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) reporting checklist. Inclusion criteria Studies was included if they describe or evaluate mobile applications (apps) designed to support self-management among individuals with diabetic kidney disease (DKD) or diabetes or chronic kidney disease. Articles must report on at least one self-management-related feature integrated into a mobile app, such as health monitoring, patient education, motivational tools, or performance feedback. Only studies published in English were included. There were no publication year, study design, or geographic location restrictions. More specifically, the inclusion criteria were: Population: Adults diagnosed with type 2 diabetes and chronic kidney disease (CKD) or diabetic kidney disease (DKD). Studies focusing on patients with both conditions, or where DKD is clearly defined, will be included. Concept: The main focus is self-management interventions delivered via mobile applications. This includes features such as self-care monitoring, education, motivation, support, and performance incentives. Context: Studies conducted in any healthcare or community setting, with mobile applications (not limited by platform) used to support self-management among DKD patients. No geographic restrictions exist, as long as the study includes relevant app-based interventions. Types of Studies: This scoping review included interventional studies (both randomised and non-randomised), observational studies (such as cohort and cross-sectional designs), and studies describing the development phase of mobile apps. Protocol papers and conference abstracts were excluded. Studies focusing on healthcare personnel, caregivers, or family members rather than patients were also excluded. Information sources Five electronic databases were systematically searched: PubMed, Scopus, SAGE Journals, ScienceDirect, and Web of Science. In addition, reference lists of the included studies were also manually screened to identify additional eligible studies; however, none met the inclusion criteria. Search strategy A comprehensive search strategy has been developed using keywords and Medical Subject Headings (MeSH) related to diabetes, chronic kidney disease, diabetic kidney disease, self-management, and mobile applications. Each database has a tailored search strategy, and Boolean operators (AND/OR) were used to refine the search queries. All databases were searched from inception to 26 th February 2025, with no limits on language set. An example of the whole search string is included in S2 Table . Study selection and data charting All search results were imported into reference management software, Zotero, and duplicates were removed. Two reviewers have independently screened titles and abstracts against the inclusion criteria. Full-text articles of potentially relevant studies were reviewed independently. Data charting was conducted using a standardised extraction form developed by the review team, which included predefined fields based on the review objectives and PCC framework. Discrepancies between reviewers have been resolved through discussion or consultation with a third reviewer when necessary. Data extraction and synthesis Relevant data were extracted into a structured form, including study characteristics, target population, mobile app features, technologies used, outcomes measures, and integration with care teams, if available. Data items The following data items have been charted: Author(s), year of publication, and country of study Study design and setting Target population (e.g., type 2 diabetes with chronic kidney disease) Mobile apps name Core functional and details of self-management features Technology used and usage of supportive technologies (e.g., sensors or wearables) Integration with care team and Outcomes measurement used Quality assessment Consistent with the scoping review methods and objective of this scoping review which are to identify and map the key features of mobile applications used for self-management among individuals with diabetic kidney disease, this study focused on providing a broad overview of the available evidence [ 9 , 10 ]. As per JBI guidelines, critical appraisal was not conducted, in line with the exploratory objectives of the review. Results A total of 11 studies [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 ] met our review criteria. Fig 1 provides a flow diagram of article identification and inclusion. Download figure Open in new tab Fig 1. Flow diagram of article selection. Table 2 summarises the main characteristics of the 11 studies included in this scoping review. These studies varied in terms of country of origin, year of publication, study design, target population, and the specific self-management features integrated into the mobile applications. Several studies also reported the use of supportive devices to enhance the app’s functionality. This overview provides context on the diversity of approaches employed in designing and implementing mobile health interventions for patients with diabetes, CKD, or DKD across different healthcare settings. View this table: View inline View popup Table 2. Characteristics of included studies Study methods The studies included in this review employed various research designs. Five studies utilized a randomized clinical trial (RCT) design [ 12 , 13 , 14 , 17 , 21 ] while three studies adopted user-centered or co-development approaches [ 11 , 15 , 20 ]. One study conducted a pilot validation [ 16 ] another employed a prospective cohort design [ 19 ] and one study carried out a descriptive technical validation [ 18 ]. Year of publication and target population The included studies were published between 2014 and 2024, with a concentration of research conducted in the past five years from 2020 to 2024. The earliest study was by Hidalgo et al. [ 18 ] in 2014, while the most recent were published in 2024. The studies targeted patients with a range of chronic conditions, primarily focusing on chronic kidney disease (CKD), diabetic kidney disease (DKD), and type 2 diabetes mellitus (T2DM). As shown in Fig 2 specifically, five studies involved CKD patients [ 11 , 12 , 15 , 19 ], two focused on DKD patients [ 14 , 16 ] and four studies targeted individuals with T2DM [ 17 , 18 , 20 , 21 ]. One study [ 18 ] included both T1DM and T2DM patients. This diversity in target populations reflects the overlapping and interrelated nature of these chronic conditions in mobile health research. Download figure Open in new tab Fig 2. Number of studies by condition Core functional domains of self-management features Table 3 shows four recurring core functional domains of self-management features were identified across the studies. As shown in Table 3 , self-care monitoring was present in ten studies, allowing users to track parameters such as blood glucose, blood pressure, and physical activity. Educational components were featured in seven studies, providing patients with disease-specific knowledge and lifestyle guidance. All eleven studies included patient support and motivational features, such as reminders, feedback, and communication tools. Lastly, performance incentive features, such as goal tracking and gamification, were incorporated in two studies [ 15 , 17 ] aimed at encouraging adherence and engagement. View this table: View inline View popup Download powerpoint Table 3. Core functional domains across the 11 studies Further details of the four key self-management domains identified across the included studies are presented in Table 4 . These domains reflect the core functionalities integrated into mobile health interventions aimed at enhancing chronic disease self-management. Among the 11 studies, patient support and motivational features were universally implemented. These included reminders, personalized feedback, peer interactions, and clinician alerts tools known to enhance adherence and user engagement. Self-care monitoring was nearly as prevalent, appearing in 10 studies [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 21 ] with features such as self-monitoring blood glucose, blood pressure, pulse and activity tracking, which some supported by wearable technology. View this table: View inline View popup Table 4. Details of core functional domains for self-management, integration, and outcome measures Educational content was incorporated in seven studies [ 11 , 15 , 16 , 17 , 18 , 19 , 20 ], delivered through interactive modules, videos, or structured text, supporting patient understanding of disease processes and lifestyle management. In contrast, performance incentives such as gamification or reward systems were reported in only two studies which one was conducted in United States [ 15 ] and the other in China [ 17 ]. Supportive devices used In addition to the use of basic mobile applications, a limited number of studies incorporated other supportive devices to enhance the functionality and user experience of self-management interventions. Out of the eleven studies reviewed, four reported the integration of additional tools. One study utilized a heart rate wristband to monitor physical activity parameters such as steps taken, calories burned, and sleep patterns [ 15 ]. Two studies employed the LINE app group function to deliver dietary and exercise information and to facilitate teleconsultations [ 13 , 16 ]. Another two studies incorporated Bluetooth-enabled glucometers, allowing users to synchronize blood glucose data directly with the mobile application for continuous monitoring [ 14 , 21 ]. Study 6 [ 16 ] integrated communication features, including chat messaging and video calls, to provide real-time interaction and support. The remaining studies did not report the use of external supportive devices and relied solely on the mobile application’s built-in features. Integration with care team and outcome measures Among all the 11 studies, only a minority demonstrated active integration between the mobile apps and healthcare providers. Some apps (e.g., DialBetesPlus and SMARTDiabetes) synchronized data with electronic medical records or allowed care teams to monitor patient progress [ 14 , 17 ]. Others (e.g., e-KidneyCare) used built-in alerts to notify providers of critical lab results or symptoms [ 12 ]. However, most apps were standalone tools, lacking bidirectional communication or real-time clinician input. The included studies reported a range of outcome measures encompassing adherence metrics (such as medication compliance and goal tracking), biometric improvements (including blood pressure, HbA1c, and weight), and patient-reported outcomes related to usability and satisfaction [ 11 , 21 ] Discussion This scoping review aimed to identify and characterize the features of mobile applications designed to support self-management among individuals with diabetic kidney disease (DKD), type 2 diabetes mellitus (T2DM), and chronic kidney disease (CKD). Given the pathophysiological overlap between these conditions particularly DKD as a progressive outcome of both T2DM and CKD, mobile apps developed for any of these populations often address similar self-management challenges. Across the reviewed studies, the most consistently implemented features included patient support and motivational tools, self-care monitoring functions, and educational components. Patient support mechanisms such as reminders, personalised feedback, peer interaction features, and messaging were universally implemented across all included studies. These features are central to enhancing treatment adherence, reinforcing lifestyle behaviours, and sustaining long-term engagement. Their consistent inclusion reflects a paradigm shift toward interactive, behaviorally informed, and patient-centred app design. This trend aligns with a growing body of evidence suggesting that supportive digital communication significantly improves adherence and health outcomes in diabetes and kidney care [ 1 , 22 ]. Self-care monitoring was also a highly prevalent domain, reported in 10 of the 11 studies. These functionalities enabled users to track various health parameters such as blood glucose, blood pressure, body weight, and physical activity either manually or through wearable device integration. Some apps, for example, employed Bluetooth-enabled glucometers, enhancing real-time data capture and user convenience. These features support the established role of physiological monitoring in optimizing glycemic and cardiovascular outcomes for patients with diabetic complications [ 2 ]. Educational content was featured in seven studies, often delivered via structured videos, app-based modules, or interactive quizzes. These components aimed to improve disease understanding, medication adherence, dietary practices, and symptom recognition. However, the degree of personalization and interactivity varied substantially. This highlights a current gap in the use of dynamic, adaptive learning systems that tailor educational content to users’ evolving needs as an area deserving further innovation and research [ 23 , 24 ]. A notable but underutilized design element identified in this review is the inclusion of performance incentives, such as gamification and reward mechanisms. These were reported in only two studies, despite emerging research demonstrating their potential to enhance behavioral outcomes and sustained user engagement [ 3 ]. Gamification elements especially achievement tracking and competition can increase motivation but must be balanced to avoid user fatigue and app abandonment [ 25 ]. A recurring trend observed in the studies was the minimal emphasis on enabling real-time communication between patients and healthcare providers. Although some apps included features like data sharing or provider alerts, very few enabled two-way, live interactions. This is a missed opportunity, especially as healthcare increasingly moves toward more connected, team-based care. Digital tools that support continuous, bidirectional communication are essential not only for urgent issues, but also to sustain long-term chronic disease management. Integrated digital systems that promote seamless provider-patient interaction are crucial for minimizing care fragmentation and improving chronic care outcomes, as highlighted by recent evaluations of digital health strategies [ 26 ]. The significance of culturally tailored integrative application design incorporating personalized education and real-time communication is demonstrated by the mobile app developed for patients with type 2 diabetes mellitus in Indonesia [ 27 ]. These examples underscore the value of embedding clinical integration and interactive support within mobile health solutions. Looking ahead, app developers should aim to blend self-management features with seamless communication and personalized support to truly enhance care continuity and patient experience. A variation in mobile app features appeared to align with the target population and geographic region. Mobile apps developed for diabetes populations (e.g., SMARTDiabetes in China [ 17 ], glUCModel in Spain [ 18 ], and Diabetes Xcel in the United States [ 20 ]) placed greater emphasis on biometric monitoring and educational content related to glycemic control and lifestyle. In contrast, CKD mobile apps like My Kidney & Me (Canada) [ 11 ] and iCKD (Switzerland) [ 19 ] focused more heavily on symptom tracking, renal-specific lab monitoring, and general wellness modules. Meanwhile, mobile apps targeting DKD (DialBetesPlus in Japan [ 14 ] and NORA in Spain [ 16 ]) incorporated hybrid functionalities that reflect the complex self-management needs of individuals living with both diabetes and kidney disease. These apps combined monitoring tools for blood glucose, blood pressure, body weight, and oxygen saturation (SpO₂), thus addressing both glycemic control and renal health. Regionally, Asian-developed apps (e.g., WowGoHealth in Taiwan [ 13 ] and Smart Glucose Manager in Sri Lanka [ 21 ]) tended to include wearable device integration and messaging features, possibly reflecting greater comfort with technology use and healthcare digitization in those contexts. This diversity implies that both the health priorities of target populations and regional technological infrastructure may shape how mobile app functionalities are prioritized. Although outcomes such as adherence, glycemic control, or usability were reported in several studies, this review did not evaluate their effectiveness. Instead, our focus remained on mapping the functional features and structural design elements of mobile apps to support self-management in DKD, T2DM, and CKD populations. This approach aligns with other recent reviews that prioritize descriptive analysis of app content and functionality over impact assessment, particularly in fields where intervention trials remain limited or heterogeneously reported [ 28 ]. Like any scoping review, this study has some limitations that are important to acknowledge. First, we did not perform a formal quality assessment of the included studies. This is consistent with the Joanna Briggs Institute’s scoping review methodology, which focuses on mapping existing evidence rather than evaluating study rigor. However, it means that the methodological quality of the reviewed studies may vary, and our findings should be interpreted with that in mind. Second, the review included only studies published in English and indexed in selected databases. This may have led us to miss relevant mobile applications described in non-English literature or grey literature such as app store listings or unpublished reports. Another key point is that our review centered on describing the features and design elements of mobile apps, not their clinical effectiveness. Despite these limitations, our study is among the first to comprehensively explore mobile health apps spanning DKD, T2DM, and CKD. By comparing self-management features across these overlapping conditions, this review highlights underutilized functionalities such as gamification and clinical integration and offers practical guidance for designing more connected, personalized, and engaging digital health tools. Conclusion This scoping review mapped the core self-management features of mobile applications designed for DKD, DM and CKD populations. While patient support tools, self-monitoring capabilities, and educational components were widely implemented, few apps integrated motivational incentives or direct communication with healthcare providers. These findings highlight the importance of incorporating bi-directional data sharing between users and healthcare providers to support real-time clinical oversight and personalized feedback. Additionally, the inclusion of behavioral reinforcement strategies such as adaptive goal setting and incentive-based features can enhance user motivation and long-term engagement. Insights from this review may serve as a valuable resource for digital health developers, nephrology and diabetes care teams, and health policymakers aiming to design more patient-centered, functionally integrated mobile health interventions. Data Availability All relevant data are within the manuscript and its Supporting Information files. Author contributions Project administration & Resources: Nani Draman Data curation: Hasmawati Yahya, Nani Draman, Najib Majdi Yaacob. Methodology: Hasmawati Yahya, Azidah Abdul Kadir, Najib Majdi Yaacob. Writing – original draft: Hasmawati Yahya Writing, review and editing: Hasmawati Yahya, Azidah Abdul Kadir. Najib Majdi Yaacob. Supporting information View this table: View inline View popup S1 Table Preferred reporting items for systematic reviews and meta-analyses extension for scoping reviews (PRISMA-ScR) checklist View this table: View inline View popup Download powerpoint S2 Table Acknowledgement This work was supported by the Universiti Sains Malaysia, Research University Team (RUTeam) Grant Scheme with Project No: 1001/PPSP/8580083, Project Code: TE0034 (Reference No: 2022/0501] References 1. ↵ Silva T , Martínez-Huertas EM , Hernández J , García-Casal MN , Martín-Carrasco M . Effectiveness of mobile applications in managing type 2 diabetes: Systematic review spanning December 2019–October 2023 . PLoS ONE . 2024 ; 19 ( 4 ): e0301523 . doi: 10.1371/journal.pone.0301523 OpenUrl CrossRef PubMed 2. ↵ Li Y , Lee M , Zhang T , Zhang L , Chen Y , Wang X , et al. Mobile health applications for diabetes and its complications: Systematic review of features and outcomes . PLoS ONE . 2025 ; 20 ( 1 ): e0305178 . doi: 10.1371/journal.pone.0305178 OpenUrl CrossRef 3. ↵ Stowell M , Dobson R , Garner K , Baig M , Nehren N , Whittaker R . Digital interventions for self-management of prediabetes: A scoping review . PLoS ONE . 2024 ; 19 ( 5 ): e0303074 . doi: 10.1371/journal.pone.0303074 OpenUrl CrossRef PubMed 4. ↵ Lorig KR , Holman H . Self-management education: History, definition, outcomes, and mechanisms . Ann Behav Med . 2003 ; 26 ( 1 ): 1 – 7 . doi: 10.1207/S15324796ABM2601_01 OpenUrl CrossRef PubMed Web of Science 5. ↵ Schulman-Green D , Jaser S , Martin F , Alonzo A , Grey M . Processes of self-management in chronic illness . J Nurs Scholarsh . 2020 ; 52 ( 2 ): 144 – 153 . doi: 10.1111/jnu.12533 OpenUrl CrossRef 6. ↵ Barlow J , Singh D , Bayer S , Curry R . A systematic review of self-management support for chronic disease: Evidence-based practice and future trends . Int J Qual Health Care . 2021 ; 33 ( 1 ): mzaa118 . doi: 10.1093/intqhc/mzaa118 OpenUrl CrossRef PubMed 7. ↵ Park C , Zhang Y , Wang C , Eirin A , Lerman LO . Digital self-management in patients with chronic kidney disease: A scoping review . BMC Nephrol . 2022 ; 23 : 80 . doi: 10.1186/s12882-022-02713-9 OpenUrl CrossRef PubMed 8. ↵ Androga LA , Amundson RH , Hickson LJ , Thorsteinsdottir B , Garovic VD , Manohar S , et al. Telehealth versus face-to-face visits: Patient perspectives in nephrology outpatient care during COVID-19 . PLoS ONE . 2022 ; 17 ( 3 ): e0265073 . doi: 10.1371/journal.pone.0265073 OpenUrl CrossRef PubMed 9. ↵ Arksey H , O’Malley L . Scoping studies: Towards a methodological framework . Int J Soc Res Methodol . 2005 ; 8 ( 1 ): 19 – 32 . doi: 10.1080/1364557032000119616 OpenUrl CrossRef 10. ↵ Peters MDJ , Godfrey CM , Khalil H , McInerney P , Parker D , Soares CB . Guidance for conducting systematic scoping reviews . Int J Evid Based Healthc . 2015 ; 13 ( 3 ): 141 – 146 . doi: 10.1097/XEB.0000000000000050 OpenUrl CrossRef PubMed 11. ↵ Lightfoot CJ , Wilkinson TJ , Nixon D , Brown P , Harris K , Jones L , et al. Co-developing ‘My Kidney & Me’: A self-management intervention for people with chronic kidney disease . PLoS ONE . 2022 ; 17 ( 9 ): e0273879 . doi: 10.1371/journal.pone.0273879 OpenUrl CrossRef 12. ↵ Ong SW , Jassil NK , Lim F , Tan K , Wong M , Chan L , et al. Evaluation of the eKidneyCare mobile application: A randomized controlled trial among patients with chronic kidney disease . PLoS ONE . 2021 ; 16 ( 10 ): e0258215 . doi: 10.1371/journal.pone.0258215 OpenUrl CrossRef PubMed 13. ↵ Li C , Hsu MH , Wang TJ , Chen J , Lin S , Chou Y , et al. Design and evaluation of the WowGoHealth mobile app for CKD self-management in Taiwan . J Med Internet Res . 2020 ; 22 ( 7 ): e18528 . doi: 10.2196/18528 OpenUrl CrossRef 14. ↵ Waki K , Fujiu K , Ohe K , Sato Y , Kobayashi K , Hagiwara N , et al. Effectiveness of the DialBetesPlus mobile app in diabetic kidney disease: A randomized controlled trial . JMIR Mhealth Uhealth . 2024 ; 12 : e51234 . doi: 10.2196/51234 OpenUrl CrossRef 15. ↵ Markossian TW , Hossain MM , Adla M , Smith R , Lee J , Patel K , et al. Design and pilot of a user-centered mobile app for chronic kidney disease self-management . BMC Nephrol . 2021 ; 22 : 134 . doi: 10.1186/s12882-021-02352-z OpenUrl CrossRef PubMed 16. ↵ Toapanta E , Valencia C , Lara J , Gomez A , Ramirez P , Flores R , et al. Development and pilot testing of NORA: A mobile app for diabetic kidney disease self-management . BMC Med Inform Decis Mak . 2024 ; 24 : 77 . doi: 10.1186/s12911-024-02288-5 OpenUrl CrossRef PubMed 17. ↵ Zhang R , Wang Y , Hu Y , Liu X , Chen Z , Li Q , et al. SMARTDiabetes: A performance-based incentive intervention using mobile technology in China . BMC Public Health . 2024 ; 24 : 180 . doi: 10.1186/s12889-024-17088-9 OpenUrl CrossRef PubMed 18. ↵ Hidalgo J , Martín-Baranera M , Carmona M , Gonzalez R , Lopez J , Perez S , et al. Development and validation of the glUCModel for diabetes self-management . J Med Syst . 2014 ; 38 ( 9 ): 99 . doi: 10.1007/s10916-014-0099-x OpenUrl CrossRef PubMed 19. ↵ Tsai YH , Yu TF , Chiang HL , Chang Y , Huang C , Wu M , et al. Evaluation of the iCKD app for chronic kidney disease: A prospective cohort study . BMC Nephrol . 2021 ; 22 : 247 . doi: 10.1186/s12882-021-02456-6 OpenUrl CrossRef PubMed 20. ↵ Berlot R , Friedman R , Sinha M , Choudhary P , Ahmed F , Wang W , et al. Diabetes Xcel app: A single-arm clinical trial for type 2 diabetes management . J Diabetes Sci Technol . 2024 ; 18 ( 2 ): 327 – 334 . doi: 10.1177/19322968231156135 OpenUrl CrossRef 21. ↵ Gunawardena D , Shariff M , Karunaratne P , Perera D , Silva H , Fernando M , et al. Effectiveness of the Smart Glucose Manager app in improving glycemic control in Sri Lanka . J Telemed Telecare . 2019 ; 25 ( 9 ): 558 – 566 . doi: 10.1177/1357633X18792744 OpenUrl CrossRef 22. ↵ Gbaba S , Turkson-Ocran RA , Renda S , Mensah R , Boateng L , Addo R , et al. Referral for diabetes self-management education and support in adult primary care: An integrative review . J Adv Nurs . 2025 ;. doi: 10.1111/jan.16719 OpenUrl CrossRef 23. ↵ Jain SR , Sui Y , Ng CH , Chen ZX , Goh LH , Shorey S . Patients’ and healthcare professionals’ perspectives towards technology-assisted diabetes self-management education: A qualitative systematic review . PLoS ONE . 2020 ; 15 ( 8 ): e0237647 . doi: 10.1371/journal.pone.0237647 OpenUrl CrossRef PubMed 24. ↵ Patail K , Pai H , Greenfield G , Smith J , Khan M , Wong A , et al. What are the perceptions and experiences of adults using mobile applications for self-management in diabetes? A systematic review . BMJ Open . 2025 ; 15 ( 1 ): e086671 . doi: 10.1136/bmjopen-2024-086671 OpenUrl Abstract / FREE Full Text 25. ↵ Sun J , Gu Y , Gu D , Liu P , Zhao M , Li S , et al. Gamification affordances in self-health management: Perspectives from achievement satisfaction and gamification exhaustion . Internet Res . 2025 ;. doi: 10.1108/intr-07-2024-1049 OpenUrl CrossRef 26. ↵ Vratimos A , Champilomatis I , Farantos G . Navigating chronic disease management with digital healthcare solutions amidst the COVID-19 pandemic: A systematic literature review . Eur Sci J . 2025 ; 21 ( 37 ): 94 . doi: 10.19044/esj.2025.v21n37p94 OpenUrl CrossRef 27. ↵ Putri DMP , Suhoyo Y , Pertiwi AAP , Effendy C . Integrated Diabetes Self-Management (IDSM) mobile application to improve self-management and glycemic control among patients with type 2 diabetes mellitus in Indonesia: A mixed methods study protocol . PLoS ONE . 2022 ; 17 ( 11 ): e0277127 . doi: 10.1371/journal.pone.0277127 OpenUrl CrossRef PubMed 28. ↵ Norouzkhani N , Norouzi S , Faramarzi M , Amini S , Jafari H , Kazemi M , et al. Developing and evaluating a gamified self-management application for inflammatory bowel disease using the ADDIE model and Sukr framework . BMC Med Inform Decis Mak . 2025 ; 25 ( 1 ): 28 . doi: 10.1186/s12911-024-02842-3 OpenUrl CrossRef PubMed View the discussion thread. Back to top Previous Next Posted August 24, 2025. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Features of mobile apps for diabetic kidney disease self-management: a scoping review Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Features of mobile apps for diabetic kidney disease self-management: a scoping review Hasmawati Yahya , Nani Draman , Azidah Abdul Kadir , Najib Majdi Yaacob medRxiv 2025.08.20.25334066; doi: https://doi.org/10.1101/2025.08.20.25334066 Share This Article: Copy Citation Tools Features of mobile apps for diabetic kidney disease self-management: a scoping review Hasmawati Yahya , Nani Draman , Azidah Abdul Kadir , Najib Majdi Yaacob medRxiv 2025.08.20.25334066; doi: https://doi.org/10.1101/2025.08.20.25334066 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Endocrinology (including Diabetes Mellitus and Metabolic Disease) Subject Areas All Articles Addiction Medicine (567) Allergy and Immunology (863) Anesthesia (297) Cardiovascular Medicine (4414) Dentistry and Oral Medicine (443) Dermatology (380) Emergency Medicine (606) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1505) Epidemiology (15208) Forensic Medicine (30) Gastroenterology (1120) Genetic and Genomic Medicine (6575) Geriatric Medicine (666) Health Economics (994) Health Informatics (4512) Health Policy (1365) Health Systems and Quality Improvement (1609) Hematology (537) HIV/AIDS (1264) Infectious Diseases (except HIV/AIDS) (15905) Intensive Care and Critical Care Medicine (1103) Medical Education (620) Medical Ethics (144) Nephrology (666) Neurology (6576) Nursing (345) Nutrition (998) Obstetrics and Gynecology (1139) Occupational and Environmental Health (955) Oncology (3319) Ophthalmology (969) Orthopedics (369) Otolaryngology (420) Pain Medicine (435) Palliative Medicine (129) Pathology (663) Pediatrics (1689) Pharmacology and Therapeutics (691) Primary Care Research (710) Psychiatry and Clinical Psychology (5423) Public and Global Health (9208) Radiology and Imaging (2192) Rehabilitation Medicine and Physical Therapy (1367) Respiratory Medicine (1193) Rheumatology (593) Sexual and Reproductive Health (709) Sports Medicine (529) Surgery (709) Toxicology (99) Transplantation (288) Urology (265) (function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'9fed8ed7aaf30704',t:'MTc3OTMwMzM1MA=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.